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Abstract: Modic changes (MCs) are believed to be potential pain generators in the lumbar and cervical
spine, but it is currently unclear if their presence affects postsurgical outcomes. We performed a
systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. All studies evaluating cervical or lumbar spine postsurgical
outcomes in patients with documented preoperative MCs were included. A total of 29 studies and
6013 patients with 2688 of those patients having preoperative MCs were included. Eight included
studies evaluated cervical spine surgery, eleven evaluated lumbar discectomies, nine studied lumbar
fusion surgery, and three assessed lumbar disc replacements. The presence of cervical MCs did not
impact the clinical outcomes in the cervical spine procedures. Moreover, most studies found that
MCs did not significantly impact the clinical outcomes following lumbar fusion, lumbar discectomy,
or lumbar disc replacement. A meta-analysis of the relevant data found no significant association
between MCs and VAS back pain or ODI following lumbar discectomy. Similarly, there was no
association between MCs and JOA or neck pain following ACDF procedures. Patients with MC
experienced statistically significant improvements following lumbar or cervical spine surgery. The
postoperative improvements were similar to patients without MCs in the cervical and lumbar spine.
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1. Introduction
Vertebral bone marrow edema is a recognized clinical entity that is believed to be
associated with degenerative disc disease and back pain [1]. The aberrant signal changes
identified with magnetic resonance imaging (MRI) were characterized into specific types by
Modic et al., and were thus termed Modic changes (MC). Each distinct signaling phenotype
is characterized by their unique signal intensity in MRI. Type I changes are characterized
by hypointense T1- and hyperintense T2-weighted images, type II changes are recognized
as hyperintense signaling on T1- and isointense to slightly hyperintense signaling on
T2-weighted imaging, while type III changes are predominantly hypointense on the T1
and T2-weighted images [1]. Histological analysis has uncovered that the MRI signal
intensity corresponds to anatomical changes. For example, type I MCs demonstrate bone
marrow replacement with fibrovascular stroma, type II MCs are associated with fatty
infiltration of the bone marrow, and type III MCs are characterized by sclerotic endplate
changes [2,3]. Longitudinal studies have suggested that these changes exist on a continuum
with transformations reported between all types, but most commonly with the progression
of type I to type II [2,4–8]. Degenerative disc disease is the most frequently identified
disease accompanying MCs [1,9,10], but other injury patterns associated with MCs include
autoimmune disease, low virulence bacterial infections, and microtrauma resulting in
endplate abnormalities [11–13].
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Given that MCs are associated with advanced spondylosis, studies have attempted to
associate MCs with axial neck and back pain [14–16]. Some authors have even attempted
to correlate type I MC with accelerated degeneration of the adjacent intervertebral disc [17].
However, while the severity of type I MCs have been linked to worse pain symptoms in
observational studies, systematic reviews have not consistently substantiated this finding [18]. A meta-analysis in 2016 attempted to identify trends in outcomes based on
pre-operative MCs and their effect on surgical outcomes. While they found a trend toward
worse improvement in lumbar discectomy patients who had MCs, they concluded that it
was unlikely that the difference met the minimal clinically important difference (MCID)
threshold [19]. However, no previous study has performed a meta-analysis on patients
undergoing cervical spine surgery, and additional literature has been published on patients
with MCs undergoing lumbar discectomy since 2016 [20–23]. Therefore, our objective was
to evaluate the impact of MCs on neck and back pain in patients undergoing cervical or
lumbar spine surgery.
This research received no external funding. All data are contained within the article.
The authors declare no conflict of interest.
2. Materials and Methods
This systematic review follows the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) Statement (Table A1). This study was IRB exempt since only
published studies were incorporated. A systematic literature review was performed of
the PubMed database from its inception until 1 May 2022. “Modic changes” or “endplate
signal changes” coupled with “outcomes” were queried. To ensure the inclusion of all of
the available evidence, the references of each study meeting the inclusion criteria were
searched to identify additional studies that merited inclusion.
2.1. Study Eligibility
Studies were included if MCs, identified in preoperative MRI, were operatively treated
in either the cervical or lumbar spine. Studies were excluded if (1) clinical follow-up time
was not reported or it was less than one year; (2) a full text manuscript could not be
obtained; (3) the article was not written in or translated to English; or (4) the article was a
letter to editor or systematic review.
Two reviewers independently screened the identified articles and selected studies
for full-text review after screening of the title and abstract. Articles were screened for
inclusion based on the predetermined inclusion/exclusion criteria during the full-text
review. A search of the references was performed of all articles meeting the inclusion
criteria to identify any potentially missed manuscripts. For studies where article inclusion
was unclear, a more senior author was consulted to resolve any discrepancies.
2.2. Data Collection Quality Assessment
The authors extracted all potentially relevant data from the identified studies with
multiple self-designed tables. Data including the type and prevalence of Modic signal
changes, clinical outcome measures, patient population, procedure type, and key study
findings were reported based on the affected region of the spine. Studies were assessed for
bias using the validated Newcastle–Ottawa Score with a high-quality score defined as a
score greater than or equal to 6 [24].
2.3. Meta-Analysis
Due to significant data heterogeneity, variability in the clinical outcome measures
assessed, and the different surgical procedures performed in the lumbar spine, only a
limited meta-analysis could be performed. For meta-analysis inclusion, a minimum of
four studies were required to report on the same patient reported outcome (PRO) with
only four PROs meeting this criteria (Visual Analog Scale (VAS) Back, VAS Neck, Oswestry
Disability Index (ODI), and Japanese Orthopedic Association (JOA) score). The weighted
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mean difference in values between patients with and without MCs was then assessed using
forest plots and data heterogeneity was calculated as an I2 value. The meta-analysis data
were generated using R Studio Version 4.0.2 (Boston, MA, USA).
3. Results
The initial PubMed search identified 259 articles, after which the title and abstract
screening identified 36 potentially relevant articles. Two were excluded due to an inadequate follow-up of less than one year [25,26], another two were excluded because of the risk
of potentially identical patients [27,28], and one article’s full-text could not be obtained [29].
Thirty-one articles were identified after a full-text review. Two studies were classified as a
high risk of bias, so they were also excluded [30,31]. In total, 29 articles were included in
the final analysis (Figure 1). The characteristics of the studies included in the systematic
review are presented in Tables 1 and 2. The included articles comprised a total of 1871
patients with cervical spine disease, 683 (36.5%) of whom displayed some type of Modic
change and 4142 patients with lumbar disease, 2005 (48.4%) of whom displayed some type
of Modic change.

Figure 1. The PRISMA flow diagram describing article selection for inclusion.

Int. J. Environ. Res. Public Health 2022, 19, 10158

4 of 18

Table 1. The patient characteristics of studies evaluating the cervical spine.
Authors

Patient Population

Modic
Subtypes

Age

Gender

Patients

Any MC (%)

MC-I (%)

MC-II (%)

Risk of
Bias

Yang et al.
[32] (2019)

Patients with cervical
radiculopathy due to
single-level disc herniation

I, II

45.2 (7.3)

131

223

41 (18.4%)

10 (4.5%)

29 (13%)

7

Baker et al.
[33] (2020)

Patients with symptomatic
degenerative pathology
refractory to conservative
management

I, II, III

NR

NR

861

356 (41.3%)

70 (8.1%)

218
(25.3%)

9

Huang et al.
[34] (2020)

Patients who underwent
single-level ACDF with MC-II

II

50.4 (1.6)

58

116

24 (20.7%)

0

24 (20.7%)

8

Li et al. [35]
(2015)

Patients who underwent
single-level ACDF with MC-II

II

47.0 (7.2)

134

248

35 (14.1%)

0

35 (14.1%)

7

Li et al. [36]
(2017)

Patients with chronic axial
symptoms resulting from
single-level radiculopathy or
myelopathy

II

56.1 (6.1)

36

76

76 (100%)

0

76 (100%)

7

Zhou et al.
[37] (2018)

Patients with cervical
spondylotic myelopathy

NR

56.1 (7.3)

56

117

28 (23.9%)

NR

NR

8

Li et al. [38]
(2022)

Patients with MCs cervical
spondylotic myelopathy with
hernia behind the vertebrae or
OPLL

I, II

55.0 (22.2)

67

124

61 (49.2%)

20 (16.1%)

41 (33.1%)

6

Li et al. [39]
(2015)

Patients with chronic axial
symptoms resulting from
single-level cervical disk
degeneration nonresponsive to
appropriate nonsurgical
treatment for at least 6 months

I, II

55.8 (6.5)

49

106

62 (58.5%)

23 (21.7%)

39 (36.8%)

7

MC—Modic changes; MC-I—type I Modic change; MC-II—type II Modic change; ACDF—anterior cervical
discectomy and fusion; OPLL—ossification of the posterior longitudinal ligament; NR—not reported.

Table 2. The patient characteristics of studies evaluating the lumbar spine.
Authors

Patient Population

MC
Subtypes

Age

Gender

Patients

Any MC (%)

MC-I (%)

MC-II (%)

Risk of
Bias

Kumarasamy et al.
[21] (2021)

Patients with LBP and single
level lumbar disc herniation

I, II

42.5
(12.6)

107

309

86 (27.8%)

6 (1.9%)

68 (22%)

7

Jiao et al. [40] (2021)

Patients with LBP and either
LDH, spinal stenosis, or
spondylolisthesis who
underwent single-segment
TLIF with a PEEK cage

I, II

56.7
(8.9)

49

89

51 (57.3%)

20 (22.5%)

31 (60.8%)

6

el Barzouhi et al.
[41] (2014)

Patients with sciatica

I, II

43.2
(10.1)

140

263

112 (42.6%)

4 (1.5%)

106
(40.3%)

8

Ulrich et al. [42]
(2020)

Patients with claudication
and lumbar stenosis

I, II

66.8
(6.3)

96

205

143 (69.8%)

22 (15.4%)

93 (65.0%)

8

Chung et al. [43]
(2021)

Patients with lumbar DDD

I, II, III

64.7
(9.1)

54

86

NR

NR

NR

7

MacLean et al. [23]
(2021)

Patients with single level
LDH

I, II, III

53 (13)

101

179

110 (61.5%)

28 (15.6%)

63 (35.2%)

7

Udby et al. [44]
(2020)

Patients with bilateral or
unilateral radiculopathy

I, II

50.5

310

620

290 (46.8%)

73 (11.8%)

217 (35%)

7

Sørlie et al. [45]
(2012)

Patients with one-level
lumbar disc herniation

I, II

41.2
(12.1)

66

178

104 (58.4%)

36 (20.2%)

68 (38.2%)

8

Gornet et al. [46]
(2014)

Patients with back pain due
to DDD with pre-op ODI ≥
30

I, II

NR

NR

89

NR

NR

NR

8

Ohtori et al. [47]
(2010)

Patients with LBP and leg
pain due to lumbar spinal
canal stenosis

I, II

65.4

16

33

33 (100%)

21 (63.6%)

12 (36.4%)

6

Cao at al [48] (2014)

Patients with one-level LDH
and MCs

I, II

NR

NR

91

91 (100%)

42 (46.2%)

60 (65.9%)

7

Lurie et al. [49]
(2013)

Patients with radicular pain
due to intervertebral disc
herniation

I, II

41.7
(11.4)

522

307

80 (26.1%)

27 (8.8%)

53 (17.3%)

7
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Table 2. Cont.
Authors

Patient Population

MC
Subtypes

Age

Gender

Patients

Any MC (%)

MC-I (%)

MC-II (%)

Risk of
Bias

Xu et al. [50] (2019)

Patients with unilateral
radicular pain due to
one-level intracanal disc
herniation

I, II

40.0
(12.5)

104

276

94 (34.1%)

44 (15.9%)

50 (18.1%)

6

Djurasovic et al.
[51] (2012)

Patients with “disc
pathology” listed as primary
surgical indication

I, II, III

47

23

51

NR

NR

NR

7

Masala et al. [52]
(2014)

Patients with LBP without
radicular symptoms
unresponsive to conservative
therapy for 6 months with
type I MC

I

40.3
(8.2)

133

218

218 (100%)

218 (100%)

0

6

Ohtori et al. [53]
(2010)

Patients with one-level LDH

I

35.5

19

45

23 (51.1%)

23 (51.1%)

0

6

Rahme et al. [54]
(2010)

Patients with one-level LDH

I, II, III

54

14

41

32 (78%)

6 (14.6%)

26 (63.4%)

7

Blondel et al. [55]
(2011)

Patients with chronic LBP
due to single-level DDD

I, II

42.1

101

221

114 (51.6%)

65 (29.4%)

49 (22.2%)

8

Gautschi et al. [56]
(2016)

Patients with LBP due to disc
herniation, spinal stenosis or
DDD requiring lumbar
fusion

I, II, III

58.6
(15.5)

144

338

202 (59.8%)

NR

NR

7

Hellum et al. [57]
(2012)

Patients with LBP due to
LDD with an ODI ≥ 30%

I, II

41.2
(7.0)

81

152

131 (85%)

48 (31.6%)

55 (36.2%)

9

Kwon et al. [58]
(2009)

Patients who underwent
PLIF

I, II, III

47.4

232

351

92 (26.2%)

26 (7.4%)

55 (15.7%)

7

MC—Modic changes; MC-I—type I Modic changes; MC-II—type II Modic change; LBP—low back pain; LDH—
lumbar disc herniation; TLIF—transforaminal lumber interbody fusion; PEEK—polyetheretherketone; DDD—
degenerative disc disease; ODI—Oswestry Disability Index; LDD—lumbar disc disease; PLIF—posterior lumbar
interbody fusion; NR—not reported.

3.1. Cervical Spine
Eight retrospective studies described the correlations between MC and surgical outcomes (Table 3). No prospective studies evaluated MC in the cervical spine. In general,
studies did not report a difference in the PROs based on the presence of MC.
Table 3. The key findings of surgery in patients with cervical Modic changes.
Authors

Objective

Study Design

Procedure

Follow-Up
(Months)

Clinical Outcome
Measures

Key Findings

Yang et al. [32]
(2019)

To report on the incidence of
MC in patients with cervical
radiculopathy due to disc
herniation

Retrospective

ACDF vs.
ACDA vs.
ACD

12

NDI, MCS-12,
PCS-12, Neck VAS,
Arm VAS

MCs were not associated with a
change in NDI, SF-12, VAS
Surgical approach did not
influence MRI-evidence of MCs

Baker et al. [33]
(2020)

To study the association of
MC with postoperative
outcomes in ACDF patients

Retrospective

ACDF

27.3

VAS Neck, Vas arm,
SF12, VR12

Overall, MCs were not
associated with post-operative
PROs

Huang et al. [34]
(2020)

To explore the impact of MC
on bone fusion after
single-level ACDF

Retrospective

ACDF

33.2

JOA score, VAS
neck, fusion rates

MCs were not associated with
post-operative PROs, but MC-II
were associated with delayed
fusion.

Li et al. [35]
(2015)

To explore the impact of
MC-II on the clinical
outcomes of single-level
ACDF

Retrospective

ACDF

60

JOA, NDI, neck VAS

MCs were not associated with
post-operative PROs or fusion
rates

Li et al. [36]
(2017)

To compare the clinical and
radiologic outcomes of
patients with MC-II who
underwent single level
ACDF or ACDA

JOA, NDI, ROM,
VAS neck, VAS arm

All patients improved from
baseline, but the ACDA group
showed greater improvement
in VAS neck and axial ROM
compared with the ACDF
group at final follow-up.

Retrospective

ACDF vs.
ACDA

60
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Table 3. Cont.
Authors

Objective

Zhou et al. [37]
(2018)

To compare the clinical and
radiological outcomes
between patients with or
without axial symptoms in
ACDF

Li et al. [38]
(2022)

To determine the impact of
MCs on cage subsidence and
fusion after ACCF

Li et al. [39]
(2015)

To analyze the influence of
MCs on the clinical results of
cervical spondylotic
myelopathy treated by ACDF

Study Design

Retrospective

Retrospective

Retrospective

Procedure

ACDF

ACCF

ACDF

Follow-Up
(Months)

Clinical Outcome
Measures

Key Findings

12

Axial symptoms

Patients with post-operative
axial symptoms were more
likely have had preoperative
MCs on endplates adjacent to
treated disc

24

Cage subsidence,
fusion rate

More patients with MCs
experienced cage subsidence.
MCs were not associated with
post-operative PROs or fusion
rates.

JOA, percent
recovered at final
follow-up visit

All patients experienced
significant improvement in all
measures. MC-I patients
reported significantly lower
VAS at 3, 6, 12, and 24 months
postop. MC-I patients had a
higher JOA at 1-year

24

MC—Modic changes; MC-I—type I Modic change, MC-II—type II Modic change; ACDF—anterior cervical discectomy and fusion; ACDA—anterior cervical discectomy with arthroplasty; ACD—anterior cervical discectomy
without intervertebral cage; NDI—neck disability index; MCS-12—mental component score from the 12-item short
form survey; PCS-12—physical component score from the 12-item short form survey; VAS—visual analog scale;
SF-12—12-itme short form survey; PROs—patient reported outcomes; JOA—Japanese Orthopedic Association;
ROM—range of motion; ACCF—anterior cervical corpectomy and fusion.

Huang et al. [34] reviewed 116 cases of single-level anterior cervical discectomy and
fusions (ACDF) for the presence of MC and their association with fusion rates and PROs.
Patients with type II MC experienced significantly delayed early fusion rates at 3- and 6months, but the fusion rates were similar at one year. There were no significant differences
between groups with regard to improvement in the VAS scores or JOA scores.
In a study by Li et al. [38] in 2022, 124 patients underwent single-level anterior cervical
corpectomy and fusion for cervical myelopathy. They found that 41% of patients with MC
had cage subsidence, defined as at least 1 mm, compared to only 15.9% of patients without
MC (p = 0.003). Subsidence did not vary between the Modic subtypes. Patients with type I
MC had a higher proportion of partial fusions, defined by incomplete bony remodeling
(40% compared to 11% of controls). No cases of pseudarthrosis were observed and no other
differences were identified with regard to the JOA, neck disability index (NDI), and VAS
neck and arm pain scores.
Yang et al. [32] retrospectively reviewed patients who underwent one-level ACDFs or
cervical disc arthroplasty. The presence of MCs did not result in different one-year VAS
neck, NDI, or physical component summary (PCS-12) and mental component summary
(MCS-12) scores from the 36-Item Short Form Health Survey (SF-36).
In a 2017 study by Li et al. [36], 72 patients were analyzed with type II MC and
minimum five-year follow-up. Of those, 35 received cervical disc arthroplasty and 37
underwent ACDF for myelopathy or radiculopathy. All patients experienced postoperative
improvement assessed by modified JOA (mJOA), NDI, and VAS, without differences
between groups. The patients in the disc replacement group were noted to have improved
range of motion at final follow-up.
In 2015, Li et al. [35] retrospectively compared 35 patients who had a single-level
ACDF with type II MC at an adjacent level to 213 patients without type II MC. They
observed no significant differences between groups with regard to the range of motion or
disc height at adjacent levels, and no differences in improvement by the mJOA and NDI
scores. The patients in the MC group had worse VAS neck pain at one-year follow-up
(p < 0.05), although these differences resolved by 5-year follow-up.
A retrospective review of 117 patients with a single-level ACDF found that preoperative MCs at levels adjacent to surgery were associated with greater axial symptoms
(p = 0.015) [37]. However, all patients demonstrated clinical improvement as assessed by
the JOA without a significant difference between patients who did and did not have MCs.
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In a separate 2015 study by Li et al. [39], 106 patients were retrospectively identified
with one-level ACDFs for cervical spondylotic myelopathy. Preoperatively, 23 patients had
type I MC, 28 had type II MC, and 44 had no MC. The patients in the type I MC group
had
neck pain
pain at
at 24
24 months
months after
after surgery
surgery (1.5
(1.5 ±
± 1.1)
had significantly
significantly lower
lower VAS
VAS neck
1.1) compared
compared to
to
patients
patients without
without (MC
(MC 2.0
2.0 ±±1.5),
1.5),although
althoughaaspecific
specificp-value
p-valuewas
wasnot
notprovided.
provided.
Baker
Baker et
et al.
al. [33]
[33] retrospectively
retrospectively examined
examined the
the records
records of
of 861
861 patients
patients who
who underwent
underwent
aa one- to four-level ACDF for radiculopathy or myelopathy. Of
those,
365
patients
Of those,
patients had
MCs.
No
significant
differences
in
postoperative
NDI,
VAS-neck,
or
VAS-arm
MCs. No significant differences in postoperative NDI, VAS-neck, or VAS-arm were found
found
between
groups. However,
However,after
afterstratification
stratificationbybycervical
cervical
level,
they
identified
presbetween groups.
level,
they
identified
thethe
presence
ence
ofat
MC
at C7–T1
predicted
postoperative
NDI
(p < 0.001).
of MC
C7–T1
predicted
worseworse
postoperative
NDI (p
< 0.001).
A
A limited
limited number
number of
of studies
studies collected
collected PROs
PROsin
inaastandardized
standardizedmanner,
manner,thus,
thus,aametametaanalysis
forfor
postoperative
values.
FourFour
studies
reported
on neck
analysis could
couldonly
onlybebeperformed
performed
postoperative
values.
studies
reported
on
pain
following
ACDF
[34,35,38,39].
Random
effects
analysis
of these
studies
neck and
pain JOA
and JOA
following
ACDF
[34,35,38,39].
Random
effects
analysis
of these
studies demonstrated
no significant
association
between
MCpostoperative
and postoperative
VASscores
neck
demonstrated
no significant
association
between
MC and
VAS neck
scores−0.17,
(MD 95%
−0.17,
CI: −0.50–1.70)
2a)JOA
or the
JOA (MD
scores
(MD95%
−0.07,
CI:
(MD
CI:95%
−0.50–1.70)
(Figure (Figure
2a) or the
scores
−0.07,
CI:95%
−0.35–
−0.35–0.20)
2b). Among
these studies,
moderate
heterogeneity
in pain
neck scores
pain scores
0.20)
(Figure(Figure
2b). Among
these studies,
moderate
heterogeneity
in neck
(I2 =
(I2 = 52%)
andheterogeneity
low heterogeneity
in scores
JOA scores
(I2 =were
0%) were
observed.
52%)
and low
in JOA
(I2 = 0%)
observed.

Figure
meta-analysis of
of one-year
one-yearpostoperative
postoperativeVAS
VASneck
neckscore
score
(A)
and
JOA
score
folFigure 2.
2. The
The meta-analysis
(A)
and
JOA
score
(B)(B)
followlowing
ACDF.
VAS—visual
analog
MC—Modic
changes;
SD—standard
deviation;
MD—
ing ACDF.
VAS—visual
analog
scale;scale;
MC—Modic
changes;
SD—standard
deviation;
MD—Mean
Mean
difference;
CI—confidence
interval;
JOA—Japanese
Orthopaedic
Association
score; df—dedifference;
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Table 4. Cont.
Authors

Objective

Study Design

Procedure

Follow-Up
(Months)

Outcome Measures

Key Findings

Jiao et al. [40]
(2021)

To analyze the influence of
MCs the clinical and
radiographic outcomes of
transforaminal lumbar
interbody fusion

Retrospective

TLIF

23.4

ODI, VAS back pain,
VAS leg pain, cage
subsidence,

MCs had no impact on fusion
rates and clinical outcomes

el Barzouhi
et al. [41] (2014)

To analyze the correlation
between MCs and back pain
in sciatica in patients with
early surgery vs.
conservative treatment

12

VAS back, 7-point
Likert self-rating
scale of global
perceived recovery

Surgically treated patients
showed an increase in extent
of MCs (67% of pts)
compared to conservatively
treated patients (19%)
No difference in
post-operative back pain
scores

Ulrich et al.
[42] (2020)

To investigate if the MCs are
predictive for outcomes in
degenerative lumbar spinal
stenosis patients undergoing
decompression-alone or
decompression with
instrumented fusion surgery

Retrospective

Decompression
vs. PLIF

36

SSM symptoms,
SSM function,
MCID in SSM
symptoms, NRS
pain, and EQ-5D
sum score over time

MCs were not associated
with clinical outcomes,
independent of the chosen
surgical operation.

Chung et al.
[43] (2021)

To evaluate the influence of
MC on the radiological
outcomes in lumbar
interbody fusion

Retrospective

OLIF

28.6

Cage subsidence,
fusion rate

MCs were not associated
with cage subsidence or
impaired fusion

MacLean et al.
[23] (2021)

To examine the relationship
between preoperative MCs
and postoperative clinical
assessment scores for
patients receiving lumbar
discectomy or TLIF for
lumbar disk herniation

12

VAS leg, SF12
physical, ODI

All patients experienced
improved from baseline, but
those with MC experienced
the greatest improvement in
disability. Outcomes were
similar in discectomy vs.
TLIF

Udby et al. [44]
(2020)

To assess whether MCs are
associated with
health-related quality of life,
long-term physical disability,
back- or leg pain after
discectomy

24

ODI, VAS back, VAS
leg, Patient
satisfaction scores,
EQ-5D

MCs were not associated
with differences in
improvement in PROs,
except for VAS back wherein
patients with MC-I had
worse scores than those with
MC-II

Sørlie et al. [45]
(2012)

To investigate whether the
presence of preoperative
MC-I represents a risk factor
for persistent back pain 12
months after surgery
amongst patients operated
for lumbar disc herniation

Retrospective

12

VAS back, VAS leg,
ODI, EQ-5D,
self-reported benefit
of the operation and
employment status

All patients improved in all
outcomes at 1-year. In
aggregate, MC were not
associated with PROs.
Patients with MC-I had less
improvement of VAS Back
and EQ-5D

Gornet et al.
[46] (2014)

To determine which variables
predict clinical outcomes
following disc replacement

Prospective

Disc
replacement

60

ODI, SF-36

Patients with MC-II had
better ODI scores at 5-year
follow-up than those with
no-MC or MC 1

Ohtori et al.
[47] (2010)

To investigate the changes in
MCs after posterolateral
fusion

Prospective

Posterolateral
fusion

24

JOA, VAS back,
ODI, fusion rate

MCs were not associated
with post-operative PROs or
fusion rates

Cao at al [48]
(2014)

To compare the outcomes of
simple discectomy and
instrumented PLIF in
patients with lumbar disc
herniation and MCs

Retrospective

Instrumented
PLIF vs.
discectomy

18

JOA, VAS back, VAS
leg

iPLIF resulted in superior
outcomes for relief of LBP
compared to simple
discectomy. Both treatments
similarly relieved radicular
leg pain

Lurie et al. [49]
(2013)

To determine whether
baseline MRI and MCs are
associated with differential
outcomes with surgery or
non-operative treatment

Retrospective

Open
discectomy and
decompression

48

ODI, bodily pain,
sciatica and back
pain symptoms,
physical function

MC-I patients had poorer
outcomes on all measures
after surgery compared to
MC-II or no MC

ODI, VAS back, VAS
leg, Patient
satisfaction scores
(Modified MacNab)

Patients with MC-I had
poorer improvement in VAS
back and ODI at 1 year and
final follow-up compared to
MC-II or no MC.
Improvements in leg pain
were comparable among
groups

Xu et al. [50]
(2019)

To assess the clinical
outcomes of TF-PELD in the
treatment of LDH and MCs

Prospective

Retrospective

Retrospective

Retrospective

Microdiscectomy

TLIF vs.
discectomy

Discectomy

Microdiscectomy

TF-PELD

29.6
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Table 4. Cont.
Authors

Objective

Study Design

Procedure

Follow-Up
(Months)

Outcome Measures

Key Findings

Djurasovic et al.
[51] (2012)

To investigate relationship
between MRI findings in
patients with DDD and
clinical improvement after
lumbar fusion

Retrospective

PLF, TLIF,
ALIF,
circumferential
fusion

24

NRS back and leg,
ODI, SF-36

MCs were not associated
with post-operative PROs

Masala et al.
[52] (2014)

To evaluate the effectiveness
of vertebral augmentation
with calcium sulfate and
hydroxyapatite resorbable
cement in patients with LBP
due to MC-I

Prospective

Vertebroplasty
with calcium
sulfate and
hydroxyapatite
resorbable
bone cement

12

VAS back, ODI

All patients experienced
improvement in pain and
disability

Ohtori et al.
[53] (2010)

To examine the relationship
between LBP after
discectomy for disc
herniation and MC 1

24

VAS back, ODI, JOA

All scores improved from
baseline. MC were not
associated with
post-operative PROs or
fusion rates

Rahme et al.
[54] (2010)

To study the impact of
surgery on the natural
history of MC

60

ODI, patient
satisfaction,
presence of
symptoms, work
status

MC were not associated with
post-operative clinical
outcomes

Blondel et al.
[55] (2011)

To analyze the influence of
MC on the clinical results of
lumbar total disc arthroplasty

Prospective

30

VAS back, VAS leg,
ODI

All groups improved in all
outcomes at final follow-up.
Patients with MC1 had the
greatest improvement in ODI
and radicular pain by final
follow-up

Gautschi et al.
[56] (2016)

To determine the relationship
of radiological grading scales
of lumbar DDD with
postoperative pain intensity,
functional impairment, and
health-related quality of life

Prospective

24

ODI, RMDI, SF-12,
PCS-12, and EQ-5D
index

No significant difference in
improvement in clinical
outcome between patients
with or without MC

Hellum et al.
[57] (2012)

To evaluate predictors of
outcome in patients treated
with disc prosthesis or
multidisciplinary
rehabilitation

Prospective

24

ODI

Patients with MC-I or MC-II
has significantly better ODI
outcomes after disc
replacement

Kwon et al.
[58] (2009)

To investigate the efficacy of
PLIF with cages in chronic
DDD with MCs

59.8

Fusion rate, Prolo’s
scale for
symptomatic
improvement, VAS
Back

Patients with MC-III had
lower fusion rate and PROs
in symptoms and pain
compared to those with other
subtypes

Prospective

Retrospective

Retrospective

Discectomy

Discectomy

Disc
replacement

Microdiscecomty,
decompression,
TLIF, PLIF, or
XLIF

Disc
replacement

PLIF w/cage

MC—Modic change; MC-I—type I Modic change; MC-II—type II Modic change; MC-III—type III Modic change;
NRS—numerical rating scale; ODI—Oswestry Disability Index; MCID—minimal clinically important difference;
TLIF—transforaminal lumbar interbody fusion; VAS—visual analog scale; PLIF—posterior lumbar interbody
fusion; SSM—spinal stenosis measure; EQ-5D—EuroQol-5D; OLIF—oblique lateral interbody fusion; SF-12—12item short form survey; PROs—patient reported outcomes; JOA—Japanese Orthopedic Association; TF-PELD—
percutaneous endoscopic lumbar discectomy via a transforaminal approach; LDH—lumbar disc herniation;
DDD—degenerative disc disease; PLF—posterior lumbar fusion; ALIF—anterior lumbar interbody fusion; LBP—
low back pain; XLIF—extreme lateral interbody fusion, RMDI—Roland–Morris Disability Index; PCS-12—physical
component score of the 12-item short form survey.

El Barzouhi et al. [41] conducted a multicenter, randomized trial of 283 patients
with sciatica. They compared microdiscectomy to conservative care. Of the 283 patients,
41 percent of patients had vertebral endplate signal changes (VESCs). No significant
differences in the amount of recovery or disabling back pain were identified between
patients with and without VESCs at one year follow-up.
Gautschi et al. [56] prospectively identified 338 patients with lumbar degenerative disc
disease. Of the 338 patients, 175 of them had a microdiscectomy. Similar outcomes for VAS
back and leg pain, ODI, Roland–Morris Disability Index, Timed Up and Go test, EuroQol-5D
(EQ-5D), and PCS-12 were identified between patients in the MC and no-MC cohorts.
Kumarasamy et al. [21] prospectively followed 309 patients undergoing microdiscectomy, 86 of whom had MC. The patients in the MC group had worse postoperative numeric
rating scale (NRS) back pain (1.6 to 1.1, p = 0.001), although the overall improvement in
both groups was 4.3 points, indicating that there was no difference in the magnitude of
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overall improvement. Both groups experienced a significant improvement in disability, but
the group without MC experienced statistically significant greater improvement, although
this did not meet the MCID threshold. Patient satisfaction, as evaluated by the MacNab
criteria, was noted to be significantly worse for patients with MCs.
Sørlie et al. [45] prospectively evaluated 178 patients undergoing microdiscectomy and
found that 36 patients had type I MCs. Multivariate analysis demonstrated no statistical
differences between groups for VAS back and leg pain, ODI, and EQ-5D. All patients had
significant improvement after surgery, although patients who smoked and had type I MCs
had less improvement.
Rahme et al. [54] retrospectively identified patients treated with lumbar microdiscectomy. They included 41 patients in the final analysis and identified 19 patients with
preoperative MC at the level of the operation. At median follow-up of 41 months, 32 patients had MCs (since four of the 22 patients without MCs converted to type I MCs and
another nine converted to type II MCs). Additionally, 60% of the type I MCs converted to
type II MCs. The study concluded that the majority of patients after a lumbar discectomy
will convert to type II MCs, but MCs do not results in worse outcomes, recurrent symptoms,
or decreased satisfaction.
Ohtori et al. [53] prospectively identified 23 patients with type I MC undergoing
lumbar discectomy and matched them to 22 patients without MC. All patients exhibited
improvement in VAS back, JOA, and ODI with no significant differences between the
groups at 12 or 24 months after surgery.
MacLean et al. [23] retrospectively analyzed 129 patients undergoing discectomy for
lumbar radiculopathy with 77 patients having MCs. They had complete outcome data
for 96 of these patients and concluded each group experienced statistically and clinically
significant improvement as assessed by the PCS-12, ODI, and VAS leg pain scores. Most
subgroups met the MCID and there were no significant differences in clinical improvement
based on the presence or absence of MCs.
Lurie et al. [49] retrospectively reviewed 307 patients treated with discectomy for radicular pain and identified 81 patients with MC. The patients with type I MC improved significantly less in ODI compared to the type II or no MC patients. However, patients with type I
MC did experience an average improvement in ODI of 26.4 points following discectomy.
Udby et al. [44] retrospectively reported on 620 patients undergoing lumbar discectomy for radiculopathy with 290 patients having MC. At two year follow-up, they
concluded that both groups had significant improvement by ODI, EQ-5D, VAS back and
leg pain, with no significant differences between groups.
Cao et al. [48] retrospectively reviewed 91 patients with lumbar disc herniation and
MC who had a combination of low back and radicular leg pain. A total of 47 patients were
treated with discectomy, while 44 underwent a posterior lumbar interbody fusion (PLIF).
All patients had significant VAS back pain improvement; however, the patients in the PLIF
group experienced greater VAS back improvement. Both groups had significant VAS leg
pain improvement and there was no postoperative difference based on the type of surgery.
Xu et al. [50] retrospectively reviewed 276 patients undergoing percutaneous endoscopic lumbar discectomy for radiculopathy and identified 94 patients with MC. They
found no differences in VAS leg pain through final follow-up of 30 months. At three
months follow-up, all patients had similar improvement in ODI and VAS back pain, however, the patients with MCs were found to have worse trending ODI and VAS back pain at
final follow-up.
Ulrich et al. [42] retrospectively identified 205 patients undergoing lumbar discectomy
or lumbar fusion. They found no differences in the outcomes between patients with MCs
versus those without MCs, regardless of the procedure type when assessing the Spinal
Stenosis Measure, EQ-5D, and NRS back pain scores at the 36 month post-surgical visit.
Over 70% of patients reached the postoperative MCID at 36 month follow-up. Thus, the
study concluded that MCs do not significantly affect the postoperative clinical outcomes.

at final follow-up.
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3.3. Lumbar Fusion
3.3.
identified.
One
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Nine studies evaluating
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lumbarfusion
fusionsurgery
surgerywere
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lateral
interbody
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tients
had substantial
improvements
the clinical
outcomes
fusion
regardless
of
the presence of MCs, with the exception of one study, which found decreased fusion rates
and worse outcomes in patients with type III MCs [58].
Chung et al. [43] retrospectively analyzed 86 patients with 125 operated levels by
one- or two-level OLIF and identified MC at 72 of these levels. They found no association
between the MC and fusion rate or cage subsidence at 28 months after surgery.
Jiao et al. [40] retrospectively identified 89 patients, 51 with MC, who underwent
single-level TLIFs. The authors found no difference in the fusion rate or clinical outcomes
based on MCs, but type I MCs were associated with significantly higher rates of cage
subsidence (40% to 15.8%). All other outcome measures were similar between groups
including disc height, segmental lordosis, and lumbar lordosis.
MacLean et al. [23] retrospectively reviewed 44 patients who underwent TLIF for
radiculopathy and instability. They concluded that patients experienced significant improvement by PCS-12, ODI, and VAS leg pain regardless of the presence of MCs.
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Two studies reported on multiple fusion techniques: TLIF, PLIF, PLF, extreme lateral
interbody fusion, circumferential fusion, and anterior lumbar interbody fusion [51,56].
Between these studies, 121-disc levels were included in their analysis with 73 levels having
MCs. No outcome measures were significantly affected by MCs including ODI, VAS back
and leg, or SF-36.
Of the two studies reporting on decompression with PLIF, Ohtori et al. [47] prospectively evaluated 33 patients with MC while Ulrich et al. [42] retrospectively identified 57
patients undergoing lumbar fusion with 41 having MCs and 16 having no MCs. All patients
in the study by Ohtori et al. [49] had solid arthrodesis at 24 months after surgery with
average union at nine months. Neither study found differences in the VAS nor ODI based
on the presence of MCs.
For patients undergoing posterolateral fusion, Kwon et al. [58] retrospectively reviewed 351 patients and identified MCs in 92 while Cao et al. [48] retrospectively identified
44 patients with MCs. Kwon et al. reported lower fusion rates for patients with type III
MCs (54.5%) compared to those without MCs (96.5%) at a minimum three years follow-up.
They also identified less improvement for those with type III MC when evaluated by Prolo’s
scale and VAS scores. Cao et al. reported that all patients had significant improvement in
the VAS back, VAS leg, and JOA.
3.4. Other Lumbar Surgeries
We identified four articles in our search that did not fit into the above categories.
Three of these studies reported on disc arthroplasty while the other study reported on
vertebroplasty. Masala et al. [52] prospectively identified 218 patients with type I MC
who underwent vertebroplasty. Of those, 98% showed improvement in VAS and ODI, 1%
showed no improvement, and 1% died for unrelated reasons. Three prospective studies
evaluated lumbar disc arthroplasty [46,55,57]. They all reported improved ODI in patients
with MC compared to those without. Gornet et al. [46] reported these findings for type
II MC, Blondel et al. [55] reported these findings for type I MC, and Hellum et al. [57]
reported these findings for both type I and II MCs.
4. Discussion
Radiographic evidence of intervertebral disc degeneration is reported to be present in
greater than 90% of individuals by the time they reach 50 years of age [59]. Most patients
with disc degeneration remain asymptomatic, but within the asymptomatic population,
21% of patients older than 60 have spinal stenosis, while 36% have a herniated intervertebral
disc [60]. Therefore, identifying potential factors that may result in back or neck pain is
prudent [61]. Modic changes are one potential etiology for symptomatic back and neck pain,
thus an evaluation of their potential improvement after surgery is indicated. Although
the heterogeneity in the literature precluded our team from performing a meta-analysis
of all of the included studies, the majority of studies assessing the surgical outcomes
after cervical and lumbar spine surgery have not detected clinically important differences
between patients with and without Modic changes. Despite heterogeneity, our metaanalysis similarly identified no differences between postoperative VAS back pain or ODI
in patients with MC undergoing lumbar discectomy. There was less data heterogeneity in
patients undergoing ACDF, and our meta-analysis found no differences in postoperative
VAS neck pain or JOA based on the presence of MCs.
Surgeons perform over 100,000 ACDFs each year [62] and MCs are present at rates
surpassing 40% in patients greater than 50 years of age who undergo cervical spine MRI [63].
The results of our pooled analysis found that MCs were present in a similar 36.5% of
patients who required cervical spine surgery. Thus, understanding the potential indicators
of surgical success (e.g., presence or absence of MCs) is important for risk stratification and
guiding the patient’s expectations on their potential postoperative clinical improvement.
When evaluating the clinical outcomes, our pooled data suggest that MCs are not predictive
of postoperative improvement in patients undergoing cervical spine surgery. While one
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study reported MCs at the level C7–T1 were associated with worse outcomes, this group
comprised 1.2% of their overall patient population and was likely severely underpowered
to detect a true difference [33]. In contrast, Li et al. [39] reported that patients with type
I MC were more likely to have reduced back pain at 2.5 year follow-up. Given that the
available data are based on retrospective studies, with approximately half the patients
coming from one study [33], it is likely that additional well-designed studies are needed to
definitively claim that MCs have no significant clinical effect on cervical spine postsurgical
outcomes. However, the evaluated studies do pose a low risk of bias, and the current
literature suggests that MCs do not significantly impact the clinical or surgical success of
cervical spine surgery [34,38].
Seven studies evaluated the microdiscectomy or discectomy outcomes in relation to
MC. While discectomy and microdiscectomy overall appear efficacious as a treatment for
axial back pain reduction and PRO improvement for patients with MCs, those with type I
MC may experience reduced improvements following discectomy. Only one study evaluating microdiscectomy identified worse improvement in patients with MCs, although this
was not clinically significant [21]. Two other retrospective studies identified a relationship
between MC and worse PRO improvement (ODI and VAS back) following discectomy. Although these studies identified discectomy as an effective treatment option for patients with
MC, patients with type I MC experienced less improvement at long-term follow-up [49,50].
Type I MC likely represents inflammatory changes, which may be linked to exacerbations
of low back pain. Despite the propensity of MC to transform to other types, they have also
been shown to remain constant over time [64]. Although discectomy may alleviate discogenic pain, it may have little effect on the concomitant changes to the vertebral endplate.
This may be one potential reason why patients with MC-I do not exhibit as robust of an
improvement when compared to other patients. While the results of our meta-analysis
indicated no differences in back pain or disability, significant heterogeneity and the limited
number of studies prohibit strong conclusions, and more research is needed, especially
comparing the improvement across MC types.
We identified eight retrospective studies and one prospective study reporting MC
in lumbar fusion surgery. These studies demonstrated that MC do not influence patientreported outcomes or fusion rates following lumbar fusion surgery regardless of approach.
Jiao et al. [40] identified that patients with type I MC experienced greater improvement in
PROs following TLIF. Kwon et al. [58] reported lower fusion rates and worse PROs in type
III MC. They suggested that given the sclerotic nature of type III MC, additional fusion such
as pedicle screw fixation may be required for patients with type III changes [58]. Although
this sclerotic bone may interfere with fusion, resorption of the sclerotic bone has been
observed over time [65]. Care should be taken when selecting patients for surgery with MCIII because this population remains understudied due to its low prevalence. While lumbar
disc replacement was evaluated in three prospective analyses and all three demonstrated
excellent results that are not affected by the presence of MC, further research is needed to
analyze the impacts of disc arthroplasty on endplate disease.
5. Conclusions
Since the last review on this topic in 2016, several prospective and large retrospective
studies have been published with a low risk of bias [19]. After summarizing all of the available data on surgical patients with MCs, quantitative and qualitative analyses suggest that
patients with MCs have similar clinical improvements in PROs (ODI and VAS back/neck)
and similar fusion rates when compared to patients without MCs. However, additional
high-quality studies are needed to further elucidate changes in the fusion status, especially
among patients with type III MC. Furthermore, long-term prospective studies evaluating
the outcomes of patients with type I MC undergoing discectomy are merited given that
some studies indicate that they have worse clinical improvement after surgery.
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Table A1. PRISMA Checklist.
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Identify the report as a systematic review, meta-analysis, or both.

1
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Provide a structured summary including, as applicable:
background; objectives; data sources; study eligibility criteria,
participants, and interventions; study appraisal and synthesis
methods; results; limitations; conclusions and implications of key
findings; systematic review registration number.

1

Rationale

3

Describe the rationale for the review in the context of what is
already known.

2

Objectives

4

Provide an explicit statement of questions being addressed with
reference to participants, interventions, comparisons, outcomes,
and study design (PICOS).

2

Protocol and registration

5

Indicate if a review protocol exists, if and where it can be accessed
(e.g., Web address), and, if available, provide registration
information including registration number.

4

Eligibility criteria

6

Specify study characteristics (e.g., PICOS, length of follow-up) and
report characteristics (e.g., years considered, language, publication
status) used as criteria for eligibility, giving rationale.

2,3

Information sources

7

Describe all information sources (e.g., databases with dates of
coverage, contact with study authors to identify additional studies)
in the search and date last searched.

2

Search

8

Present full electronic search strategy for at least one database,
including any limits used, such that it could be repeated.

2

Study selection

9

State the process for selecting studies (i.e., screening, eligibility,
included in systematic review, and, if applicable, included in the
meta-analysis).
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TITLE
Title
ABSTRACT

Structured summary

INTRODUCTION

METHODS

Int. J. Environ. Res. Public Health 2022, 19, 10158

15 of 18

Table A1. Cont.
Section/Topic

Number

Checklist Item

Reported on
Page Number
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Describe method of data extraction from reports (e.g., piloted
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Data items

11

List and define all variables for which data were sought (e.g.,
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made.

3

Risk of bias in individual
studies
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Describe methods used for assessing risk of bias of individual
studies (including specification of whether this was done at the
study or outcome level), and how this information is to be used in
any data synthesis.

3

Summary measures
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State the principal summary measures (e.g., risk ratio, difference in
means).
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Synthesis of results
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Describe the methods of handling data and combining results of
studies, if done, including measures of consistency (e.g., I2 ) for each
meta-analysis.
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Risk of bias across studies
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Specify any assessment of risk of bias that may affect the
cumulative evidence (e.g., publication bias, selective reporting
within studies).

3

Additional analyses
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Describe methods of additional analyses (e.g., sensitivity or
subgroup analyses, meta-regression), if done, indicating which
were pre-specified.
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Study selection
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Give numbers of studies screened, assessed for eligibility, and
included in the review, with reasons for exclusions at each stage,
ideally with a flow diagram.

3

Study characteristics
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For each study, present characteristics for which data were
extracted (e.g., study size, PICOS, follow-up period) and provide
the citations.
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Risk of bias within studies
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Present data on risk of bias of each study and, if available, any
outcome level assessment (see item 12).

3, Tables 1
and 2

Results of individual studies

20

For all outcomes considered (benefits or harms), present, for each
study: (a) simple summary data for each intervention group (b)
effect estimates and confidence intervals, ideally with a forest plot.
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Synthesis of results
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Present results of each meta-analysis done, including confidence
intervals and measures of consistency.

9, 15 (Figures 2
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Risk of bias across studies
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Present results of any assessment of risk of bias across studies (see
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3, Tables 1
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Additional analysis
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Give results of additional analyses, if done (e.g., sensitivity or
subgroup analyses, meta-regression [see Item 16]).
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Summary of evidence
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Summarize the main findings including the strength of evidence for
each main outcome; consider their relevance to key groups (e.g.,
health care providers, users, and policy makers).
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Limitations
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